​

Funding Round

Series B - Cardurion Pharmaceuticals

Series B - Cardurion Pharmaceuticals

Investment Firm

Overview

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Announced Date

Jul 16, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Ascenta Capital

Ascenta Capital

Ascenta Capital is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

11

Investor Name
Participant InvestorInvus
Participant InvestorGoogle Ventures
Participant InvestorNew Enterprise Associates
Participant InvestorFidelity
Participant InvestorFarallon Capital Management

Round Details and Background

Cardurion Pharmaceuticals raised $260000000 on 2024-07-16 in Series B

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 20, 2019
Series A - Cardurion Pharmaceuticals
1-undefined
Oct 27, 2021
Series B - Cardurion Pharmaceuticals
4-300.0M
Dec 30, 2022
Debt Financing - Cardurion Pharmaceuticals
-17.5M
Jul 16, 2024
Series B - Cardurion Pharmaceuticals
12-260.0M

Recent Activity

There is no recent news or activity for this profile.